These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 17516739)

  • 1. Prostate Cancer in Male-to-Female Transgender Individuals: Histopathologic Findings and Association With Gender-affirming Hormonal Therapy.
    Baraban E; Ding CC; White M; Vohra P; Simko J; Boyle K; Guo C; Zhang M; Dobs A; Ketheeswaran S; Liang F; Epstein JI
    Am J Surg Pathol; 2022 Dec; 46(12):1650-1658. PubMed ID: 36006769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eruptive Papules as a Cutaneous Manifestation of Metastatic Prostate Adenocarcinoma.
    Onalaja-Underwood AA; Sokumbi O
    Am J Dermatopathol; 2023 Dec; 45(12):828-830. PubMed ID: 37883967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: Squamous cell carcinoma of the prostate-a clinicopathological and genomic sequencing-based investigation.
    Zhang C; Jia Y; Kong Q
    Pathol Oncol Res; 2023; 29():1611343. PubMed ID: 38089646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic adenocarcinoma: molecular underpinnings and treatment-related options.
    Paralkar D; Akbari A; Aron M
    Urol Oncol; 2024 Jul; 42(7):203-210. PubMed ID: 38508940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the autonomic nervous system contribute to the initiation and progression of prostate cancer?
    Ventura S; Evans BA
    Asian J Androl; 2013 Nov; 15(6):715-6. PubMed ID: 24141535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential cancer-specific survival with curative radiotherapy to the prostate for metastatic prostate cancer according to estimated survival by risk group.
    Shiota M; Terada N; Kimura T; Kitamura H; Kamoto T; Eto M;
    Int J Urol; 2023 Dec; 30(12):1197-1199. PubMed ID: 37565462
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between Prostate Carcinoma and Multiple Myeloma.
    Pokhrel A; Heravi O; Enayati L; Nelson R; Mooppan U; Wu R; Wang JC
    Discov Med; 2023 Oct; 35(178):664-672. PubMed ID: 37811608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JTH in clinic: A new series for the practicing clinician.
    Connors JM
    J Thromb Haemost; 2021 Jan; 19(1):51. PubMed ID: 33405378
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic efficacy and interobserver agreement among readers with variable experience of the Prostate Imaging for Recurrence Reporting system with whole-mount histology after androgen deprivation therapy as a reference.
    Chen Z; Zhou B; Liu W; Gan H; Chen R; Yang L; Zhou L; Liu X
    Quant Imaging Med Surg; 2024 Apr; 14(4):3006-3017. PubMed ID: 38617164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncologic Impact and Safety of Pre-Operative Radiotherapy in Localized Prostate and Bladder Cancer: A Comprehensive Review from the Cancerology Committee of the Association Française d'Urologie.
    Sargos P; Supiot S; Créhange G; Fromont-Hankard G; Barret E; Beauval JB; Brureau L; Dariane C; Fiard G; Gauthé M; Mathieu R; Roubaud G; Ruffion A; Renard-Penna R; Neuzillet Y; Rouprêt M; Ploussard G
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can quantitative analysis of multi-parametric MRI independently predict failure of focal salvage HIFU therapy in men with radio-recurrent prostate cancer?
    Rakauskas A; Shah TT; Peters M; Randeva JS; Hosking-Jervis F; Schmainda MJ; Orczyck C; Emberton M; Arya M; Moore C; Ahmed HU
    Urol Oncol; 2021 Dec; 39(12):830.e1-830.e8. PubMed ID: 34049783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological and functional alterations of the prostate tissue during clinical progression in hormonally-naïve, hormonally-treated and castration-resistant patients with metastatic prostate cancer.
    Korček M; Sekerešová M; Makarevich AV; Gavurová H; Olexíková L; Pivko J; Barreto L
    Oncol Lett; 2020 Nov; 20(5):201. PubMed ID: 32963607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial.
    Fendler WP; Calais J; Eiber M; Simko JP; Kurhanewicz J; Santos RD; Feng FY; Reiter RE; Rettig MB; Nickols NG; Kishan AU; ; Slavik R; Carroll PR; Lawhn-Heath C; Herrmann K; Czernin J; Hope TA
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):501-508. PubMed ID: 32808077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dataset for the reporting of prostate carcinoma in radical prostatectomy specimens: updated recommendations from the International Collaboration on Cancer Reporting.
    Kench JG; Judge M; Delahunt B; Humphrey PA; Kristiansen G; Oxley J; Rasiah K; Takahashi H; Trpkov K; Varma M; Wheeler TM; Zhou M; Srigley JR; Egevad L
    Virchows Arch; 2019 Sep; 475(3):263-277. PubMed ID: 31098802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy.
    Beltran H; Wyatt AW; Chedgy EC; Donoghue A; Annala M; Warner EW; Beja K; Sigouros M; Mo F; Fazli L; Collins CC; Eastham J; Morris M; Taplin ME; Sboner A; Halabi S; Gleave ME
    Clin Cancer Res; 2017 Nov; 23(22):6802-6811. PubMed ID: 28842510
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of histopathological features of needle biopsy in recurrent prostate cancer following salvage high-intensity focused ultrasound.
    Billia M; Siddiqui KM; Chan S; Li F; Al-Zahrani A; Gomez JA; Chin JL
    Can Urol Assoc J; 2016; 10(11-12):416-422. PubMed ID: 28096917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of immunohistochemistry markers in the interpretation of post-high-intensive focussed ultrasound prostate biopsy cores.
    Walter B; Weiss T; Hofstädter F; Gaumann A; Hartmann A; Rogenhofer S; Ganzer R; Wach S; Engehausen D; Wieland WF; Blana A
    World J Urol; 2013 Oct; 31(5):1129-33. PubMed ID: 22350516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of prohibitin in growth control and tumor suppression in human cancers.
    Wang S; Faller DV
    Transl Oncogenomics; 2008 Feb; 3():23-37. PubMed ID: 21566741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of prostatic carcinoma after therapy.
    Bostwick DG; Meiers I
    Arch Pathol Lab Med; 2007 Mar; 131(3):360-71. PubMed ID: 17516739
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.